Pfizer to buy Wyeth for $68 billion, cuts dividend

NEW YORK (Reuters) – Pfizer Inc, the No. 1 drugmaker, said on Monday that it would acquire U.S. rival Wyeth for about $68 billion in a move to diversify its revenue base.

Leave a Reply